HKHiromi W. L. Koh

Hiromi W. L. Koh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hiromi W. L. Koh has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Proteomic Insights Into Spinal Muscular Atrophy using Patient-Derived Motor Neurons and Hepatocytes

    by Hiromi Wl Koh, Yang Kai Ng, Damien M.K. Leow, Loo Chien Wang, Siok Ghee Ler, Wei Hong Jeff Chor, Gunaseelan Narayanan, Richard Giadone, Radoslaw Mikolaj Sobota, Shi Yan Ng, et al.

    Objective:While Spinal Muscular Atrophy (SMA) is classically defined by motor neuron loss, increasing evidence points to broader systemic involvement, including the liver. Current innovative therapies do not fully address this as their main aim is to improve motor function and overall survival by targeting the motor neurons in SMA patients. We investigated shared and tissue-specific molecular changes in liver and motor neurons to understand systemic effects of SMA in SMA patients and carriers.Methods:Using patient-derived stem cells from SMA patients, we generated induced liver (iHeps) and motor neuron (iMNs) cells. Using genome editing, we further created isogenic carrier and wild-type lines from the same SMA patient. We studied the proteomic differences in SMA across liver and motor neurons and determined shared and tissue-specific effects.Results:A total of 432 proteins (9.3% iHep-specific, 64.8% iMN-specific and 24.9% shared) were found dysregulated in either tissue. Commonly dysregulated proteins in both tissues included those upregulated in cell structure and extracellular matrix organization; and downregulated in mitochondrial function and metabolism-related processes. We further narrowed down to 36 proteins showing SMN-dependent effects involved in protein hydroxylation, tissue organization, wound healing and cell adhesion. In isogenic SMA carriers, cross-tissue dysregulation was limited to five proteins, with broader pathway perturbations largely tissue-specific.Interpretation:Our findings reinforce SMA’s multi-system nature, even in apparently asymptomatic carriers. Patient-derived stem cell models offer a powerful platform to understand the multi-systemic nature of SMA and gain insights into the full spectrum of its biology. These insights could inform systemic treatment approaches for SMA and SMA carriers.

  • Open Access

    Liver Steatosis in Induced Hepatocytes From Carriers of Spinal Muscular Atrophy

    by Lingyu Sun, Damien Meng Kiat Leow, Loo Chien Wang, Michelle Yating Eio, Hiromi W. L. Koh, Zi Jian Khong, Gunaseelan Narayanan, Aloysius Kai Soon Teo, Richard Giadone, Radoslaw M. Sobota, et al.

    Introduction/Aims: Although classically characterized as a motor neuron disease, spinal muscular atrophy (SMA) is increasingly recognized as a multisystem disorder. We previously showed hepatocyte‐intrinsic steatosis in SMA, raising the question of whether SMA carriers, who are typically asymptomatic, may also exhibit subclinical hepatic abnormalities. Methods: We generated induced hepatocyte‐like cells (iHeps) from induced pluripotent stem cells (iPSCs) derived from an SMA Type 2 proband, his isogenic wild‐type (Iso‐WT) line, and both carrier parents, comprised of three carrier lines from the father and one from the mother. Steatosis was assessed by Oil Red O staining and image analysis. Survival motor neuron (SMN) expression was evaluated by immunoblotting. Proteotranscriptomic profiling and mitochondrial respiration assays were performed. Risdiplam, an SMN2 splicing modulator, was used to assess reversibility of observed phenotypes. Results: SMA and carrier iHeps demonstrated increased lipid accumulation compared to Iso‐WT. Risdiplam reduced steatosis by 65.9% in SMA patient‐derived iHeps and by 43.6% and 56.9% in father‐ and mother carrier–derived iHeps, respectively. Carrier and SMA iHeps exhibited downregulation of genes involved in lipid metabolism and liver function, along with altered expression of lipid‐related proteins. Mitochondrial dysfunction was present only in SMA iHeps. Carrier‐derived induced motor neurons showed normal viability under oxidative stress, consistent with preserved neuromuscular function clinically. Discussion: Our data reveal hepatocyte‐intrinsic lipid metabolic defects in SMA carriers, partially reversible with risdiplam. These findings suggest subclinical hepatic involvement in carriers and support further investigation into the systemic impact of SMN deficiency.

  • Atopic dermatitis in children: Untargeted proteomics highlights the interaction between barrier dysfunction and immune dysregulation as key pathways

    by Sean Wee, Anna de Beer, Hiromi Wl Koh, Jocelyn Ong, Jing Hui Low, Yan Ting Lim, Shi Mei Wang, Radoslaw M. Sobota, Elena Goleva, Donald Y. M. Leung, et al.

  • Open Access

    Untargeted proteomics highlights interaction between barrier dysfunction and immune dysregulation as key pathways in Atopic Dermatitis in Children

    by Sean Wee, Anna de Beer, Hiromi Koh, Jocelyn Ong, Jing Hui Low, Yan Ting Lim, Shi Mei Wang, Radoslaw Sobota M, Elena Goleva, Donald Leung, et al.

    Background: Atopic Dermatitis (AD) is a chronic condition characterised by recurrent skin lesions and itch, significantly impacting patients’ quality of life. AD is most common during childhood, with global prevalence ranging between 10% and 20%. Objective: Identifying protein biomarkers underlying AD in children, to better understand the pathogenesis. Methods: Cross-sectional study using untargeted tandem mass spectrometry to analyse skin tape protein extracts from 71 10-year-old Singaporean children. Subjects were stratified into three groups, no history of AD (NoAD=29), history of AD but no symptoms at time of sample collection (PastAD=22) and present AD (PresentAD=20). Significant proteins were shortlisted and functional analyses were performed. Results: 397 differentially expressed proteins were identified (p-valueConclusions: Multiple protein biomarkers and pathways, including keratinization, inflammatory responses and oxidative stress response, are involved in the onset and persistence of AD. Despite resolution of disease manifestations in PastAD subjects, functional analyses show that some pathways and biomarkers indicative of AD persist.

  • Open Access

    Engineering cell-free systems by chemoproteomic-assisted phenotypic screening

    by Zarina Levitskaya, Zheng Ser, Hiromi Koh, Wang Shi Mei, Sharon Chee, Radoslaw Mikolaj Sobota, John F. Ghadessy

    Phenotypic screening identified drugs capable of improving the yeast lysate cell-free protein synthesis (CFPS) yield. A drug target gene identified using mass spectrometry proteomics was deleted to yield a yeast strain with higher productivity CFPS.


  • Open Access

    Variability of the Plasma Lipidome and Subclinical Coronary Atherosclerosis

    by Sock Hwee Tan, Hiromi W.L. Koh, Jing Yi Chua, Bo Burla, Ching Ching Ong, Li San Lynette Teo, Xiaoxun Yang, Peter I. Benke, Hyungwon Choi, Federico Torta, et al.

    Objective: While the risk of acute coronary events has been associated with biological variability of circulating cholesterol, the association with variability of other atherogenic lipids remains less understood. We evaluated the longitudinal variability of 284 lipids and investigated their association with asymptomatic coronary atherosclerosis. Approach and Results: Circulating lipids were extracted from fasting blood samples of 83 community-sampled symptom-free participants (age 41–75 years), collected longitudinally over 6 months. Three types of coronary plaque volume (calcified, lipid-rich, and fibrotic) were quantified using computed tomography coronary angiogram. We first deconvoluted between-subject (CV g ) and within-subject (CV w ) lipid variabilities. We then tested whether the mean lipid abundance was different across groups categorized by Framingham risk score and plaques phenotypes (lipid-rich, fibrotic, and calcified). Finally, we investigated whether visit-to-visit variability of each lipid was associated with plaque burden. Most lipids (72.5%) exhibited higher CV g than CV w . Among the lipids (n=145) with 1.2-fold higher CV g than CV w , 26 species including glycerides and ceramides were significantly associated with Framingham risk score and the 3 plaque phenotypes (false discovery rate <0.05). In an exploratory analysis of person-specific visit-to-visit variability without multiple testing correction, high variability of 3 lysophospholipids (lysophosphatidylethanolamines 16:0, 18:0, and lysophosphatidylcholine O-18:1) was associated with lipid-rich and fibrotic (noncalcified) plaque volume while high variability of diacylglycerol 18:1_20:0, triacylglycerols 52:2, 52:3, and 52:4, ceramide d18:0/20:0, dihexosylceramide d18:1/16:0, and sphingomyelin 36:3 was associated with calcified plaque volume. Conclusions: High person-specific longitudinal variation of specific nonsterol lipids is associated with the burden of subclinical coronary atherosclerosis. Larger studies are needed to confirm these exploratory findings.


  • Open Access

    Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy

    by Yan Ming Tan, Yan Gao, Guoshou Teo, Hiromi W.L. Koh, E Shyong Tai, Chin Meng Khoo, Kwok Pui Choi, Lei Zhou, Hyungwon Choi

    We conducted untargeted metabolomics analysis of plasma samples from a cross-sectional case–control study with 30 healthy controls, 30 patients with diabetes mellitus and normal renal function (DM-N), and 30 early diabetic nephropathy (DKD) patients using liquid chromatography-mass spectrometry (LC-MS). We employed two different modes of MS acquisition on a high-resolution MS instrument for identification and semi-quantification, and analyzed data using an advanced multivariate method for prioritizing differentially abundant metabolites. We obtained semi-quantification data for 1088 unique compounds (~55% lipids), excluding compounds that may be either exogenous compounds or treated as medication. Supervised classification analysis over a confounding-free partial correlation network shows that prostaglandins, phospholipids, nucleotides, sugars, and glycans are elevated in the DM-N and DKD patients, whereas glutamine, phenylacetylglutamine, 3-indoxyl sulfate, acetylphenylalanine, xanthine, dimethyluric acid, and asymmetric dimethylarginine are increased in DKD compared to DM-N. The data recapitulate the well-established plasma metabolome changes associated with DM-N and suggest uremic solutes and oxidative stress markers as the compounds indicating early renal function decline in DM patients.


  • Open Access

    iOmicsPASS: network-based integration of multiomics data for predictive subnetwork discovery

    by Hiromi W. L. Koh, Damian Fermin, Christine Vogel, Kwok Pui Choi, Rob M. Ewing, Hyungwon Choi

    Computational tools for multiomics data integration have usually been designed for unsupervised detection of multiomics features explaining large phenotypic variations. To achieve this, some approaches extract latent signals in heterogeneous data sets from a joint statistical error model, while others use biological networks to propagate differential expression signals and find consensus signatures. However, few approaches directly consider molecular interaction as a data feature, the essential linker between different omics data sets. The increasing availability of genome-scale interactome data connecting different molecular levels motivates a new class of methods to extract interactive signals from multiomics data. Here we developed iOmicsPASS, a tool to search for predictive subnetworks consisting of molecular interactions within and between related omics data types in a supervised analysis setting. Based on user-provided network data and relevant omics data sets, iOmicsPASS computes a score for each molecular interaction, and applies a modified nearest shrunken centroid algorithm to the scores to select densely connected subnetworks that can accurately predict each phenotypic group. iOmicsPASS detects a sparse set of predictive molecular interactions without loss of prediction accuracy compared to alternative methods, and the selected network signature immediately provides mechanistic interpretation of the multiomics profile representing each sample group. Extensive simulation studies demonstrate clear benefit of interaction-level modeling. iOmicsPASS analysis of TCGA/CPTAC breast cancer data also highlights new transcriptional regulatory network underlying the basal-like subtype as positive protein markers, a result not seen through analysis of individual omics data.


  • Open Access

    iOmicsPASS: a novel method for integration of multi-omics data over biological networks and discovery of predictive subnetworks

    by Hiromi W.L. Koh, Damian Fermin, Kwok Pui Choi, Rob Ewing, Hyungwon Choi

    We developed iOmicsPASS, an intuitive method for network-based multi-omics data integration and detection of biological subnetworks for phenotype prediction. The method converts abundance measurements into co-expression scores of biological networks and uses a powerful phenotype prediction method adapted for network-wise analysis. Simulation studies show that the proposed data integration approach considerably improves the quality of predictions. We illustrate iOmicsPASS through the integration of quantitative multi-omics data using transcription factor regulatory network and protein-protein interaction network for cancer subtype prediction. Our analysis of breast cancer data identifies network signatures surrounding established markers of molecular subtypes. The analysis of colorectal cancer data highlights a protein interactome surrounding key proto-oncogenes as predictive features of subtypes, rendering them more biologically interpretable than the approaches integrating data without a priori relational information. However, the results indicate that current molecular subtyping is overly dependent on transcriptomic data and crude integrative analysis fails to account for molecular heterogeneity in other -omics data. The analysis also suggest that tumor subtypes are not mutually exclusive and future subtyping should therefore consider multiplicity in assignments. Availability: https://github.com/cssblab/iOmicsPASS


  • The Pittsburgh Sleep Quality Index in a multi-ethnic Asian population contains a three-factor structure

    by Hiromi W. L. Koh, Raymond Boon Tar Lim, Kee Seng Chia, Wei Yen Lim

    The Pittsburgh Sleep Quality Index (PSQI) is a widely used measure for assessing sleep impairment. Although it was developed as a unidimensional instrument, there is much debate that it contains multidimensional latent constructs. We examined the dimensionality of the underlying factor structure of PSQI in Singapore, a rapidly industrialising Asian country with multi-ethnicities representing the Chinese, Malays and Indians. The PSQI was administered through an interviewer-based questionnaire in two separate population-based cross-sectional surveys. An explanatory factor analysis (EFA) was first used to explore the underlying construct of the PSQI in both studies. Then, a confirmatory factor analysis (CFA) was conducted to evaluate an optimal factor model by comparing against other possible models identified in EFA. There are three correlated yet distinguishable factors that account for an individual’s sleep experience from the same best-fit model obtained in both studies: perceived sleep quality, daily disturbances and sleep efficiency. Our three-factor structure of PSQI is superior to the originally intended unidimensional model. Our model also shows the best-fit indices when compared to the previously reported single-factor, two-factor and three-factor (by Cole et al.) models in a multi-ethnic Asian population. There is strong evidence that the PSQI contains a three-factor rather than a unidimensional structure in a multi-ethnic Asian population. Scoring the PSQI along their multidimensional perspectives may provide a more accurate understanding of the relationship between sleep impairment and health conditions rather than using a single global score.